Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine/Atropine for GI Recovery After Colorectal Surgery
NCT07271875Phase 3Not yet recruiting
- Sponsor
- Xijing Hospital
- Start
- Jan 2026
- Primary completion
- Nov 2027
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
A Phase 3 trial of Sugammadex in Postoperative gastrointestinal dysfunction (POGD), postoperative ileus (POI), sponsored by Xijing Hospital. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
Sugammadex
03
Conditions
Postoperative gastrointestinal dysfunction (POGD)postoperative ileus (POI)
Beyond the preview
Go deeper on NCT07271875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07271875.